Literature DB >> 1173698

Amyloidosis of the orbit and adnexae.

D M Knowles, F A Jakobiec, M Rosen, G Howard.   

Abstract

Five patients representing a spectrum of orbital and adnexal amyloidosis are presented. One patient with conjunctival amyloidosis did not have antecedent infection nor systemic disease (primary localized amyloidosis), while another patient with conjunctival amyloidosis had a long history of repeated attacks of bacterial conjunctivitis (secondary localized amyloidosis). The third patient presented with serial bilateral lacrimal gland amyloid without systemic disease (primary localized orbital amyloidosis). Another patient had intraorbital amyloid associated with metastatic deposits or immunoglobulin-producing lymphoma cells in the orbit (secondary systemic amyloidosis) and a fifth patient, with borderline Congo red staining for amyloid, was shown by electron microscopy to have macrophages with intracellular amyloid-like fibrils and extracellular crystalline material resembling immunoglobulin deposits. Amyloidosis has been clearly shown to be associated with immunoglobulins and plasma cells. Electron microscopic findings in our two cases of primary localized orbital amyloidosis leave unresolved the suggestion that mesenchymal cells, in addition to plasma cells, may be responsible for the production of amyloid. It should be emphasized for the clinician that amyloidosis of the conjunctiva and orbit is almost always a benign disease without systemic implications. On the other hand, amyloid of the skin of the eyelids, is a hallmark of generalized amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173698

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  11 in total

Review 1.  Imaging of focal amyloid depositions in the head, neck, and spine: amyloidoma.

Authors:  Hemant Parmar; T Rath; M Castillo; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

2.  Primary localised amyloidosis of the orbit.

Authors:  I E Murdoch; T J Sullivan; I Moseley; P N Hawkins; M B Pepys; S Y Tan; A Garner; J E Wright
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

Review 3.  Monoclonal origin of localised orbital amyloidosis detected by molecular analysis.

Authors:  S Pasternak; V A White; R D Gascoyne; S R Perry; R L Johnson; J Rootman
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

4.  Primary local orbital amyloidosis: biochemical identification of the immunoglobulin light chain kappaIII subtype in a small formalin fixed, paraffin wax embedded tissue sample.

Authors:  B Kaplan; B M Martin; H I Cohen; J Manaster; Y Kassif; U Rehany; A Livneh
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

5.  Amyloidosis of lacrimal gland: authors' reply.

Authors:  Sowmya Raveendra Murthy; Kalpana Babu; Anitha Mahadevan; Venkatesh C Prabhakaran
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

6.  Amyloid corneal deposition in corneal buttons of congenital hereditary endothelial dystrophy (CHED) - A clinical and histopathological case series.

Authors:  Abdulmajid Al-Shehah; Ali Al-Rajhi; Hind Alkatan
Journal:  Saudi J Ophthalmol       Date:  2010-10-06

7.  Primary orbital amyloidosis localised to an extraocular muscle.

Authors:  G E Holmström; K G Nyman
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

8.  Amyloidosis of lacrimal gland.

Authors:  Vinod Kumar; Neha Goel; Luke Nicholson; Jai Shankar
Journal:  Indian J Ophthalmol       Date:  2010 Jul-Aug       Impact factor: 1.848

9.  Amyloidosis of lacrimal gland.

Authors:  Venkatesh C Prabhakaran; Kalpana Babu; Anitha Mahadevan; Sowmya Raveendra Murthy
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

10.  Focal Amyloidosis of the Orbit Presenting as a Mass: MRI and CT Features.

Authors:  Hasan Yerli; Erdinc Aydin; Suat Avci; Nihan Haberal; Sibel Oto
Journal:  Iran J Radiol       Date:  2011-12-25       Impact factor: 0.212

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.